Long-Term Vonoprazan and Acotiamide-Refractory Patients With Functional Dyspepsia Partly Exhibit Pancreatic Enzyme Abnormalities
Long-term vonoprazan alone or vonoprazan and acotiamide combination therapy significantly improved each FD symptom. The OTE in patients treated with vonoprazan alone or vonoprazan and acotiamide combination therapy was only 50%. Long-term vonoprazan and acotiamide combination therapy may differentiate patients with pancreatic enzyme abnormalities from those with FD.
Authors
- Takeshi Onda (ORCID: https://orcid.org/0000-0003-4722-1954)
- Shuhei Agawa
- Rie Kawawa
- Seiji Futagami (ORCID: https://orcid.org/0000-0003-0502-8646)
- Katsuhiko Iwakiri (ORCID: https://orcid.org/0000-0002-5558-6104)
- Mayu Habiro
- Ken Nakamura (ORCID: https://orcid.org/0000-0002-9192-182X)
- Nobue Ueki
- S. Higashida
Institutions
- Nippon Medical School Hospital (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- Cureus
- Published
- 2024-09-28
- DOI
- https://doi.org/10.7759/cureus.70371
- Citations
- 2
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.93